Live news related to INVENTIVA stock (FR0013233012): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Inventiva has announced a temporary suspension of its stock trading on Euronext Paris due to a public offering in the United States.
The biopharmaceutical company Inventiva has announced its intention to raise approximately $125 million through a public offering of American Deposita…
Inventiva has announced the availability of documents for its upcoming mixed general meeting scheduled for November 27, 2025.
Inventiva stands out from the general apathy of the French market. The stock is up 5.56% mid-day while the CAC 40 is down 0.51%. This divergence refle…
Inventiva recorded another significant trading session increase this Wednesday at market close, surpassing the 3.76 euros mark. This rise comes amid a…
The biopharmaceutical company's stock closed the session on Wednesday, October 15 at €3.64, down 9% from the previous day when it traded at €4. This d…
The biopharmaceutical company's stock closed lower this Thursday, despite several recent communications.
Inventiva, a biopharmaceutical company, will present four abstracts related to digital pathology at the upcoming American Association for the Study of…
The French biotech recorded a 5.82% increase this Tuesday, closing at €4.00, while the CAC 40 slightly declined by 0.18%.
